Studies have shown that hybrid solutions can lead to better patient outcomes. For example, the combination of chemotherapy and immunotherapy has been shown to improve survival rates in certain types of cancer, such as non-small cell lung cancer. Similarly, combining targeted therapy with radiation therapy has been effective in treating cancers like glioblastoma, a type of brain cancer.
